BioSpace News Archive

Proscia®, a leading provider of AI-enabled digital pathology solutions, has made available the Concentriq Dx® digital pathology software for use in reviewing and reporting of digital pathology slides in the United States.

Boehringer Ingelheim Animal Health announced the appointment of Randolph Legg as the new Head of U.S. Commercial Business.

According to the report, the global angioplasty balloons & stents market was valued at US$ 5.9 Bn in 2018 and is projected to expand at a CAGR of 4.5% from 2019 to 2027

Ipsen achieved Hexvix 2019 sales of EUR 18.7 million and Photocure sees significant growth opportunities in Europe

Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that it has filed Patent Application Number 63012510 – Artificial Intelligence driven rapid screening system for infectious diseases, such as SARS-CoV-2 virus responsible for COVID-19, with the United States Patent and Trademark Office.

Purdue Pharma’s Avrio Health Donates $1.6 Million Worth of Betadine ® Antiseptic Products for Use by Frontline Healthcare Workers

In light of the unprecedented demand and urgent need for products that can help fight COVID-19—including cleaning products—as an interim policy, Health Canada is facilitating access to products that may not fully meet current regulatory requirements.

Ethos Research & Development has been awarded a Phase 1 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the auspices of the Small Business Innovation Research (SBIR) program and National Institutes of Health (NIH). The grant will be utilized to develop a urinary biomarker panel and softwa

April 27, 2020 19:00 UTC Personal Genome Diagnostics Receives FDA Clearance for PGDx elio™ tissue complete , the First Comprehensive Genomic Profiling Diagnostic Kit for Oncology PGDx elio™ tissue complete is the industry’s first and only clinical next-generation sequencing (NGS) diagnostic kit for comprehensive tumor profiling that is FDA-cleared for use in labs across the country PGDx elio™ tissue complete increases patient access to precision-based comprehensive genomic

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, reported very strong final study performance data for its SARS-CoV-2 antibody test.